These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8939778)

  • 21. Ipriflavone: an important bone-building isoflavone.
    Head KA
    Altern Med Rev; 1999 Feb; 4(1):10-22. PubMed ID: 9988779
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of ipriflavone administration on bone mass and metabolism in ovariectomized women.
    Gambacciani M; Spinetti A; Cappagli B; Taponeco F; Felipetto R; Parrini D; Cappelli N; Fioretti P
    J Endocrinol Invest; 1993 May; 16(5):333-7. PubMed ID: 8320424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effect of oral ipriflavone on the rat mandible during growth.
    Maki K; Nishida I; Kimura M
    Eur J Orthod; 2005 Feb; 27(1):27-31. PubMed ID: 15743860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The combination of genistin and ipriflavone prevents mammary tumorigenesis and modulates lipid profile.
    Hooshmand S; Khalil DA; Murillo G; Singletary K; Kamath SK; Arjmandi BH
    Clin Nutr; 2008 Aug; 27(4):643-8. PubMed ID: 18571816
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of short-term glucocorticoid administration on bone mineral density, biomechanics and microstructure in rats' femur.
    Chen Y; Huang L; Zhu J; Wu K
    Hum Exp Toxicol; 2017 Mar; 36(3):287-294. PubMed ID: 27193967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ipriflavone down-regulates endothelin receptor levels during differentiation of rat calvarial osteoblast-like cells.
    Hagiwara H; Naruse M; Adachi C; Inoue A; Hiruma Y; Otsuka E; Naruse K; Demura H; Hirose S
    J Biochem; 1999 Jul; 126(1):168-73. PubMed ID: 10393335
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics of ipriflavone, an isoflavone derivative, after intravenous and oral administration to rats hepatic and intestinal first-pass effects.
    Kim SH; Lee MG
    Life Sci; 2002 Feb; 70(11):1299-315. PubMed ID: 11883708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiosteoporotic activity of Du-Zhong-Wan water extract in ovariectomized rats.
    Li F; Yang X; Bi J; Yang Z; Zhang C
    Pharm Biol; 2016 Sep; 54(9):1857-64. PubMed ID: 26760929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in the histomorphometric and biomechanical properties of the proximal femur of ovariectomized rat after treatment with the phytoestrogens genistein and equol.
    Tezval M; Sehmisch S; Seidlová-Wuttke D; Rack T; Kolios L; Wuttke W; Stuermer KM; Stuermer EK
    Planta Med; 2010 Feb; 76(3):235-40. PubMed ID: 19764010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The mineralization of bone tissue: a forgotten dimension in osteoporosis research.
    Boivin G; Meunier PJ
    Osteoporos Int; 2003; 14 Suppl 3():S19-24. PubMed ID: 12730799
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strontium ranelate changes the composition and crystal structure of the biological bone-like apatite produced in osteoblast cell cultures.
    Querido W; Campos AP; Martins Ferreira EH; San Gil RA; Rossi AM; Farina M
    Cell Tissue Res; 2014 Sep; 357(3):793-801. PubMed ID: 24859219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel ipriflavone receptors coupled to calcium influx regulate osteoclast differentiation and function.
    Miyauchi A; Notoya K; Taketomi S; Takagi Y; Fujii Y; Jinnai K; Takahashi K; Chihara K; Fujita T
    Endocrinology; 1996 Aug; 137(8):3544-50. PubMed ID: 8754785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of parathyroid hormone-stimulated resorption in cultured fetal rat long bones by the main metabolites of ipriflavone.
    Giossi M; Caruso P; Civelli M; Bongrani S
    Calcif Tissue Int; 1996 Jun; 58(6):419-22. PubMed ID: 8661483
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of ipriflavone--a synthetic derivative of natural isoflavones--on bone mass loss in the early years after menopause.
    Gennari C; Agnusdei D; Crepaldi G; Isaia G; Mazzuoli G; Ortolani S; Bufalino L; Passeri M
    Menopause; 1998; 5(1):9-15. PubMed ID: 9689189
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory effect of ipriflavone on pit formation in mouse unfractionated bone cells.
    Notoya K; Yoshida K; Taketomi S; Yamazaki I; Kumegawa M
    Calcif Tissue Int; 1992; 51 Suppl 1():S3-6. PubMed ID: 1422982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of ipriflavone in the prevention and treatment of postmenopausal osteoporosis.
    Kovács AB
    Agents Actions; 1994 Mar; 41(1-2):86-7. PubMed ID: 8079827
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of ipriflavone and its metabolites on a clonal osteoblastic cell line.
    Benvenuti S; Tanini A; Frediani U; Bianchi S; Masi L; Casano R; Bufalino L; Serio M; Brandi ML
    J Bone Miner Res; 1991 Sep; 6(9):987-96. PubMed ID: 1665005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic changes of ipriflavone in rats with acute renal failure induced by uranyl nitrate.
    Chung HJ; Lee MG
    Biopharm Drug Dispos; 2006 Oct; 27(7):345-51. PubMed ID: 16902944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of ipriflavone and its two metabolites, M1 and M5, after the intravenous and oral administration of ipriflavone to rat model of diabetes mellitus induced by streptozotocin.
    Lee DY; Chung HJ; Choi YH; Lee U; Kim SH; Lee I; Lee MG
    Eur J Pharm Sci; 2009 Dec; 38(5):465-71. PubMed ID: 19761842
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered material properties are responsible for bone fragility in rats with chronic kidney injury.
    Iwasaki Y; Kazama JJ; Yamato H; Matsugaki A; Nakano T; Fukagawa M
    Bone; 2015 Dec; 81():247-254. PubMed ID: 26187196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.